Clinical Trials Logo

Post-Traumatic Headache clinical trials

View clinical trials related to Post-Traumatic Headache.

Filter by:

NCT ID: NCT05404113 Completed - Headache Disorders Clinical Trials

Sustained Natural Apophyseal Glide and Deep Friction Massage in Patients With Cervicogenic Headache

Start date: September 14, 2022
Phase: N/A
Study type: Interventional

The aim of this randomized controlled trial is to compare the effects of sustained natural apophyseal glide and deep friction massage in patients with cervicogenic headache for reducing pain, enhancing cervical range of motion and improving sleep quality.

NCT ID: NCT05397977 Active, not recruiting - Clinical trials for Cervicogenic Headache

Comparison of the Effects of Mechanical Traction and Manual Traction on Cervicogenic Headache

Start date: February 10, 2022
Phase: N/A
Study type: Interventional

52 people between the ages of 18-45 who were diagnosed with cervicogenic headache by the physician who applied to the Physical Medicine and Rehabilitation Department of Bursa VM Medical Park Hospital will be included in the research. 52 people will be randomized. They will be divided into two groups, 26 people in the study group and 26 people in the control group. The study group will be called the mechanical traction group (CTG), and the control group will be called the manual traction group (MTG). After obtaining the demographic information of the individuals to be included in the study, the cases will be evaluated with the visual analogue scale (VAS) and Mc-Gill Melzack Pain Questionnaire for head and neck pain before and after treatment. Cervical joint range of motion will be measured with an electrogoniometer, and muscle tone will be measured with myotonometer (MyotonPRO). Flexion and extension endurance tests will be performed on the cervical region muscles. Headache Impact Scale (HIT-6) will be performed to evaluate the functional status of the patients. Posture of patients will be evaluated with Corbin Posture Analysis. Pittsburgh Sleep Quality Index will be used to evaluate the sleep quality of the patients. All patients will be informed about the study. An informed consent form will be obtained from each. The mechanical traction group (CTG) and the manual traction group (MTG) will be treated for 6 days and 2 weeks. Intermittent traction with chattanooga tru trac traction device will be applied to CTG, and manual traction, one of Cyriax's neck mobilization techniques, will be applied to MTG.transcutaneous electrical nerve stimulation (TENS), hotpack and ultrasound will be applied to both groups, and an exercise program will be given in the form of a home program.

NCT ID: NCT05378074 Recruiting - Clinical trials for Post-Traumatic Headache

Hypersensitivity to Opening of BKCa Channels in Post-Traumatic Headache

Start date: September 1, 2022
Phase: N/A
Study type: Interventional

The aim is to investigate whether opening of large conductance calcium-activated potassium (BKCa) channels induces headache with migraine-like features in people with persistent post-traumatic headache (PTH) attributed to mild traumatic brain injury (mTBI).

NCT ID: NCT05378061 Recruiting - Clinical trials for Post-Traumatic Headache

Hypersensitivity to PACAP-38 in Post-Traumatic Headache

Start date: June 16, 2022
Phase: N/A
Study type: Interventional

The aim is to investigate whether signaling molecule PACAP-38 induces headache with migraine-like features in people with persistent post-traumatic headache (PTH) attributed to mild traumatic brain injury (mTBI).

NCT ID: NCT05328635 Recruiting - Clinical trials for Post-Concussion Syndrome

Post-traumatic Headache Multidisciplinary Study

PTHMS
Start date: September 1, 2021
Phase:
Study type: Observational

The study will investigate the effect of pharmacological preventive treatment, education, physiotherapy and psychological counselling on the headache and associated symptoms in patients refered to the Danish Headache Center

NCT ID: NCT05312645 Recruiting - Clinical trials for Cervicogenic Headache

Diclofenac Gel in the Treatment of Cervicogenic Headache

DITCH
Start date: June 2024
Phase: Phase 3
Study type: Interventional

The intervention will consist of the nursing staff applying 2 grams of diclofenac 1% gel topically to the posterior cervical region four times daily. The control group will receive petroleum jelly topically to the posterior cervical region four times daily. Patients will receive a pre-intervention and post-intervention survey incorporating the Numeric Assessment Scale and Headache Impact Test-6.

NCT ID: NCT05302479 Recruiting - Clinical trials for Cervicogenic Headache

Validating a Modified COMPASS 31questionnaire for Treatment Outcomes

COMPASS
Start date: April 15, 2022
Phase:
Study type: Observational

Eligible participants will complete the COMPASS 31 (year), modified COMPASS 31(one month) and the NSI (one month) questionnaires at baseline and complete the modified COMPASS 31 and the NSI after usual care of treatment. The investigators will 1. Compare results for the COMPASS 31(year) to the modified COMPASS 31(month) at baseline. 2. Compare modified COMPASS 31(month) to the NSI at baseline and post intervention.

NCT ID: NCT05289414 Not yet recruiting - Clinical trials for Cervicogenic Headache

Radiofrquency Targeting Mid Cervical Medial Branches vs GON in Cervicogenic Headache

Start date: September 2022
Phase: Phase 2/Phase 3
Study type: Interventional

To detect the Clinical efficacy of pulsed radiofrequency treatment targeting the mid cervical medial branches versus greater occipital nerve for cervicogenic headache

NCT ID: NCT05249647 Completed - Clinical trials for Cervicogenic Headache

Instrument Based Fascial Abrasion Versus Myofascial Release Technique in Cervicogenic Headache Patients

Start date: January 25, 2022
Phase: N/A
Study type: Interventional

Study will be randomized clinical trial. Data will be collected from non probability consecutive sampling technique. Total 44 participants from Rafiqa Hospital and District Headquarter (DHQ) Sargodha will be selected and randomly allocated to two different groups i.e Group A and Group B. Group A will be treated with Instrument assisted Fascial Abrasion and Conventional Therapy for 5 minutes, 6 sessions (3 sessions per week) (12) while Group B will be treated with Myofascial Release Technique and Conventional Therapy for 2 to 3 minutes, 5-7 repetitions and 3 sessions per week on alternate days were given for 6 weeks. NPRS, MOS-36, NDI will be used as outcome measuring tool before and after treatment. Data will be analyzed by using Statistical package for social sciences 25.

NCT ID: NCT05243953 Completed - Clinical trials for Post-Traumatic Headache

Hypersensitivity to Opening of ATP-Sensitive Potassium Channels in Post-Traumatic Headache

Start date: March 21, 2022
Phase: N/A
Study type: Interventional

The aim is to investigate whether opening of ATP-sensitive potassium (KATP) channels induces headache with migraine-like features in people with persistent post-traumatic headache (PTH) attributed to mild traumatic brain injury (mTBI).